Does Enhanced Vitamin D Activity In Bone Heal The Skeleton In Disorders Of FGF23 Excess?
Funder
National Health and Medical Research Council
Funding Amount
$855,925.00
Summary
X-linked hypophosphatemia (XLH) is a genetic disorder which results in phosphate wasting and rickets. This severe disorder has no effective treatment. We have compelling new evidence that the rickets in XLH is not primarily a disorder of low blood phosphate, but rather specific issue of low cellular levels and activity of vitamin D (1,25D) within bone. This proposal is designed to specifically demonstrate this new concept and outline a new paradigm for a new XLH treatment.
Monitoring Bone Loss And Response To Therapy Through Bone Material And Structural Composition
Funder
National Health and Medical Research Council
Funding Amount
$696,111.00
Summary
Millions of scripts are filled for treatment of osteoporosis. However, there is no way of knowing if these drugs are right for these individuals, if it improves bone strength or are actually doing harm. Bone density measurement is of limited value. We have developed a new analysis method that measures changes in bone structure that tell us if the treatment is or is not working so alternative treatment can be used. The aim of this study is to test this new method.
Does Teriparatide Reverse Osteonecrosis Of The Jaw In Patients With Cancer? A Randomised, Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$137,700.00
Summary
Osteonecrosis of the jaw (ONJ) is a debilitating bone condition involving damage and suboptimal healing of bone involving the jaw. This has been associated with bisphosphonate therapy, which is commonly used for the treatment of both cancer and osteoporosis. My research aims to investigate the role of recombinant parathyroid hormone in the stimulation of bone formation and healing and, thus, its potential to reverse ONJ.
Dietary Protein Effects In Elderly Women: Musculoskeletal, Renal, Cardiovascular And Body Composition Endpoints
Funder
National Health and Medical Research Council
Funding Amount
$478,946.00
Summary
Fractures and falls of the elderly are major health problems in our community in terms of disability and cost. It is critical to the future health of our aging population to develop non-pharmaceutical interventions to maintain health into old age. Epidemiologic studies have shown that relatively high protein intake is associated with increased bone mineral mass and reduced incidence of osteoporotic fracture in elderly people. Low protein intakes can lead to loss of muscle mass. To date there hav ....Fractures and falls of the elderly are major health problems in our community in terms of disability and cost. It is critical to the future health of our aging population to develop non-pharmaceutical interventions to maintain health into old age. Epidemiologic studies have shown that relatively high protein intake is associated with increased bone mineral mass and reduced incidence of osteoporotic fracture in elderly people. Low protein intakes can lead to loss of muscle mass. To date there have been no randomised trials of sufficient duration to examine the effects of increased dietary protein intake on bone and muscle health of the elderly. The aim of this study is to examine the effectiveness of protein supplementation for the prevention of osteoporosis and muscle wasting in elderly women, and the safety of such an intervention through monitoring renal function and risk factors for cardiovascular disease. Two hundred and twenty women will be recruited to this study and be assigned to protein group or placebo group. Women in the protein group will received 250 ml high protein drink (containing 30 g protein) per day and women in the placebo group will receive placebo drink containing the same amount of energy, calcium but no additional protein. Bone structure, muscle mass, body composition, renal function and risk factors for cardiovascular disease will be monitored during the 2 year study period. The results of this randomised, controlled study will clarify the role of protein on bone mass and structure, muscle mass and body composition in the elderly. At the same time, the safety of such intervention on renal and cardiovascular endpoints will also be evaluated. It is envisaged that the results of this study if positive will translate into both immediately applicable intervention strategies that are relevant at a program and an individual level.Read moreRead less
Regulation Of Bone Resorption And Formation In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$5,596,183.00
Summary
Bone is continually being formed and broken down, and these two processes are critical forthe maintenance of a normal skeleton. These processes are dependent upon communication between the bone building and degrading cells, and the hormones growth factors and cytokines that are present in the circulation or produced in bone. The tightly regulated processes of bone formation and degradation need to remain equal, and are essential for the achievement and maintenance of skeletal strength and form. ....Bone is continually being formed and broken down, and these two processes are critical forthe maintenance of a normal skeleton. These processes are dependent upon communication between the bone building and degrading cells, and the hormones growth factors and cytokines that are present in the circulation or produced in bone. The tightly regulated processes of bone formation and degradation need to remain equal, and are essential for the achievement and maintenance of skeletal strength and form. Osteoporosis results from an excess of bone breakdown over formation, and our Program aims to identify the factors that regulate these processes, and develop new therapies that can modify them. We will also determine what it is about bone cell properties that make some cancers, especially those of breast and prostate, particularly prone to spread to bone.Read moreRead less
The Effect Of Androgen Replacement Therapy On Bone And Muscle Health In Men With Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$122,714.00
Summary
Low testosterone (T) levels are common in men with poor kidney function. Low T is known to cause reduced energy, decreased strength and low libido. Normal T is also needed for healthy bones and muscles. Men with kidney disease are already at risk of fractures, poor strength and quality of life. However, there are few studies that look at replacing T to men with kidney failure. We will investigate how low T affects bone and muscle and assess how giving T can benefit bone, muscle and function.
Menopause is one of the important risk factors for bone loss, structural decay and bone fragility. We aim to quantify the biochemical, microstructural and biomechanical basis of loss of bone strength during and after menopause. A cohort of 324 pairs of female-female twins aged 25 to 75 years old will be followed up for up to 9 years. Defining the structural basis of bone fragility provides a rational means to identifying women at risk for fracture.